What's happened
The U.S. Department of Justice has reached a settlement with Walmart over alleged violations of the Controlled Substances Act tied to opioid dispensing. The company has not admitted liability. The settlement resolves claims dating back to 2013, with previous related actions already settled in 2022. Walmart shares edged higher as the deal was announced today.
What's behind the headline?
Analysis
- The settlement marks a continued DOJ focus on pharmacy compliance in the opioid crisis, aligning Walmart with CVS and Walgreens in facing penalties for dispensing practices.
- This update consolidates Walmart’s position after a years-long litigation process, with the company reiterating its commitment to supporting pharmacists and patient care.
- The move could influence future penalties and compliance expectations for large retailers in the pharmaceutical supply chain.
How we got here
The settlement follows a long-running DOJ case that began with a 2020 complaint accusing Walmart of failing to report suspicious opioid prescriptions and red flags. Walmart previously paid $3.1 billion in 2022 to settle thousands of lawsuits tied to the opioid crisis. The case came amid broader DOJ actions against pharmacies and distributors in the opioid epidemic.
Our analysis
- New York Post reports a settlement has been reached with Walmart; the government has emphasized accountability for dispensing practices. - Al Jazeera notes the DOJ did not disclose terms and that Walmart described the settlement as immaterial, while highlighting previous settlements and case history. - CNBC and other outlets corroborate that the DOJ described resolving obligations under the CSA and that Walmart said it will continue supporting pharmacists, with a focus on the opioid crisis.
Go deeper
- What are the next steps for Walmart’s pharmacy operations?
- How might the settlement influence future penalties for similar cases?
- Will other opioid-related settlements emerge from the DOJ’s broader crackdown?
More on these topics
-
Controlled Substances Act - United States anti-drug law
The Controlled Substances Act (CSA) is the statute establishing federal U.S. drug policy under which the manufacture, importation, possession, use, and distribution of certain substances is regulated. It was passed by the 91st United States Congress as Title II of the Comprehensive Drug Abuse Prevention and Control Act of 1970 and signed into law by President Richard Nixon. The Act also served as the national implementing legislation for the Single Convention on Narcotic Drugs. The legislation created five schedules (classifications), with varying qualifications for a substance to be included in each. Two federal agencies, the Drug Enforcement Administration (DEA) and the Food and Drug Administration (FDA), determine which substances are added to or removed from the various schedules, although the statute passed by Congress created the initial listing. Congress has sometimes scheduled other substances through legislation such as the Hillory J. Farias and Samantha Reid Date-Rape Prevention Act of 2000, which placed gamma hydroxybutyrate (GHB) in Schedule I and sodium oxybate (the isolated sodium salt in GHB) in Schedule III when used under an FDA New Drug Application (NDA) or Investigational...
-
Arkansas - US State
Arkansas is a state in the south central region of the United States, home to more than three million people as of 2018. Its name is from the Osage language, of Siouan derivation; it denoted their related kin, the Quapaw people.
-
Wilmington - City in Delaware
Wilmington is the largest and most populous city in the U.S. state of Delaware. The city was built on the site of Fort Christina, the first Swedish settlement in North America.
-
AmerisourceBergen - Wholesale company
AmerisourceBergen Corporation is an American drug wholesale company that was formed by the merger of Bergen Brunswig and AmeriSource in 2001. They provide drug distribution and consulting related to medical business operations and patient services.
-
Colm Connolly - United States federal judge for the District of Delaware
Colm Felix Connolly (born October 18, 1964) is the Chief United States district judge of the United States District Court for the District of Delaware. He formerly served as United States Attorney for the District of Delaware.
-
Delaware - US State
Delaware is one of the 50 states of the United States, in the Mid-Atlantic region. It is bordered to the south and west by Maryland, north by Pennsylvania, and east by New Jersey and the Atlantic Ocean.
-
United States Centers for Disease Control and Prevention - Public agency
The Centers for Disease Control and Prevention is a national public health institute in the United States. It is a United States federal agency, under the Department of Health and Human Services, and is headquartered in Atlanta, Georgia.